Perphenazine

From WikiMD's Wellness Encyclopedia

(Redirected from Trilafon)

What is Perphenazine?[edit | edit source]

  • Perphenazine (Trilafon) is a piperazinyl phenothiazine, used to treat the symptoms of schizophrenia.
  • It is also used to control severe nausea and vomiting in adults.
Perphenazine
Perphenazine3Dan2
Perphenazine2D



What are the uses of this medicine?[edit | edit source]

  • Perphenazine (Trilafon) is used for treatment of schizophrenia and for the control of severe nausea and vomiting in adults.

limitations of use:

  • Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.


How does this medicine work?[edit | edit source]

  • Perphenazine (per fen' a zeen) is a piperazine phenothiazine derivative which acts by postsynaptic inhibition of dopamine receptors.
  • Perphenazine has other peripheral and central nervous system effects, producing both alpha adrenergic stimulation and blocking histamine- and serotonin-mediated effects.


Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in:


What drug interactions can this medicine cause?[edit | edit source]

  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Be sure to mention any of the following:


Is this medicine FDA approved?[edit | edit source]

  • Perphenazine is indicated for the therapy of acute and chronic psychosis and is also used for management of nausea and vomiting.
  • Perphenazine was approved for use in the United States in 1957 and was formerly a commonly prescribed antipsychotic, but in recent years, has been replaced in large part by the atypical antipsychotics, which have fewer extrapyramidal side effects.


How should this medicine be used?[edit | edit source]

Recommended dosage: Moderately disturbed nonhospitalized patients with schizophrenia:

  • 4 to 8 mg t.i.d. initially; reduce as soon as possible to minimum effective dosage.

Hospitalized patients with schizophrenia:

  • 8 to 16 mg b.i.d. to q.i.d.; avoid dosages in excess of 64 mg daily.

Severe nausea and vomiting in adults:

  • 8 to 16 mg daily in divided doses; 24 mg occasionally may be necessary, early dosage reduction is desirable.

Elderly Patients:

  • Geriatric dosages of perphenazine preparations have not been established, but initiation of lower dosages is recommended.


Administration:

  • Perphenazine comes as a tablet to take by mouth.
  • It is usually taken two to four times a day.
  • Take perphenazine at around the same times every day.
  • Your doctor may start you on an average dose of perphenazine and decrease your dose once your symptoms are controlled.
  • Be sure to tell your doctor how you are feeling during your treatment with perphenazine.
  • Perphenazine may help to control your symptoms but will not cure your condition.
  • Continue to take perphenazine even if you feel well.
  • Do not stop taking perphenazine without talking to your doctor.
  • If you suddenly stop taking perphenazine, you may experience withdrawal symptoms such as nausea, vomiting, stomach pain, dizziness, and shakiness.
  • Your doctor will probably decrease your dose gradually and may prescribe other medication(s) for you to take for several weeks after you stop taking perphenazine.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As oral tablets containing 2 mg, 4 mg, 8 mg, and 16 mg of perphenazine.

This medicine is available in fallowing brand namesː

  • Trilafon


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

Additional side effects may include:


What special precautions should I follow?[edit | edit source]

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fluphenazinehydrochloride is not approved for the treatment of patients with dementia-related psychosis.
  • Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with neuroleptic (antipsychotic) drugs. If signs and symptoms of tardive dyskinesia appear in a patient on neuroleptics, drug discontinuation should be considered. However, some patients may require treatment despite the presence of the syndrome.
  • A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with antipsychotic drugs.
  • The use of this drug may impair the mental and physical abilities required for driving a car or operating heavy machinery.
  • Perphenazine tablets may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other injuries.
  • Antipsychotic drugs elevate prolactin levels; the elevation persists during chronic administration.
  • Patients on large doses of a phenothiazine drug who are undergoing surgery should be watched carefully for possible hypotensive phenomena. Moreover, reduced amounts of anesthetics or central nervous system depressants may be necessary.
  • Since phenothiazines and central nervous system depressants (opiates, analgesics, antihistamines, barbiturates) can potentiate each other, less than the usual dosage of the added drug is recommended and caution is advised when they are administered concomitantly.
  • Use with caution in patients who are receiving atropine or related drugs because of additive anticholinergic effects
  • Use with caution in patients who will be exposed to extreme heat or phosphorus insecticides.
  • The use of alcohol should be avoided, since additive effects and hypotension may occur.
  • Blood counts and hepatic and renal functions should be checked periodically.
  • The use of phenothiazine derivatives in patients with diminished renal function should be undertaken with caution.
  • Use with caution in patients suffering from respiratory impairment due to acute pulmonary infections, or in chronic respiratory disorders such as severe asthma or emphysema.
  • Gastritis, nausea and vomiting, dizziness, and tremulousness have been reported following abrupt cessation of high-dose therapy. Reports suggest that these symptoms can be reduced by continuing concomitant antiparkinson agents for several weeks after the phenothiazine is withdrawn.
  • Because photosensitivity has been reported, undue exposure to the sun should be avoided during phenothiazine treatment.
  • Perphenazine can cause mild and transient serum enzyme elevations and is a rare cause of clinically apparent acute and chronic cholestatic liver injury.


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Management of overdosage:

  • In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.
  • Overdose related information is also available online at poisonhelp.org/help.
  • In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.
  • Treatment is symptomatic and supportive.
  • Induction of emesis is not recommended because of the possibility of a seizure, CNS depression, or dystonic reaction of the head or neck and subsequent aspiration.
  • Gastric lavage (after intubation, if the patient is unconscious) and administration of activated charcoal together with a laxative should be considered.
  • There is no specific antidote.
  • Standard measures (oxygen, intravenous fluids, corticosteroids) should be used to manage circulatory shock or metabolic acidosis.
  • An open airway and adequate fluid intake should be maintained.
  • Body temperature should be regulated.
  • Hypothermia is expected, but severe hyperthermia may occur and must be treated vigorously
  • An electrocardiogram should be taken and close monitoring of cardiac function instituted if there is any sign of abnormality.
  • Close monitoring of cardiac function is advisable for not less than five days.
  • Vasopressors such as norepinephrine may be used to treat hypotension, but epinephrine should NOT be used.
  • Hemodialysis and peritoneal dialysis are of no value because of low plasma concentrations of the drug.


Can this medicine be used in pregnancy?[edit | edit source]

  • Perphenazine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
  • Neonates exposed to antipsychotic drugs, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.


Can this medicine be used in children?[edit | edit source]

  • Perphenazine products are not recommended for pediatric patients under 12 years of age.


What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredient:

  • perphenazine

Inactive ingredients:

  • black iron oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium starch glycolate, talc, titanium dioxide, yellow iron oxide.


Who manufactures and distributes this medicine?[edit | edit source]

Dist. by:

Mfg. by:

  • Par Formulations Private Limited,
  • 9/215, Pudupakkam, Kelambakkam.
  • Made in India


What should I know about storage and disposal of this medication?[edit | edit source]

  • Store at 20° to 25°C (68° to 77°F).
  • Dispense in a tight, light-resistant container.


Antipsychotic agents[edit source]

First Generation

Second Generation (Atypicals)

Perphenazine Resources
Wikipedia




WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju